No Data
No Data
Cantor Fitzgerald Initiates Verona Pharma at Overweight
Ritedose Adds Seventh Syntegon Packaging Line to Expand Single Vial Packaging Capabilities, Support Production of New COPD Drug Ohtuvayre
Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update
Insiders At Verona Pharma Sold US$24m In Stock, Alluding To Potential Weakness
Verona Pharma Down Over 8%, on Pace for Largest Percent Decrease Since March 2023 -- Data Talk
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading